Applied DNA Sciences (STU:UDJ) YoY EBITDA Growth : -6.09% (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Applied DNA Sciences YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Applied DNA Sciences's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was -6.09%.

Applied DNA Sciences's EBITDA per Share for the three months ended in Mar. 2024 was €-3.63.

Applied DNA Sciences YoY EBITDA Growth Historical Data

The historical data trend for Applied DNA Sciences's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Applied DNA Sciences YoY EBITDA Growth Chart

Applied DNA Sciences Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

YoY EBITDA Growth

Get a 7-Day Free Trial

38.08

66.67

45.91

0.40

51.93

Applied DNA Sciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															17.04	32.75	24.33	-263.20	-6.09

Applied DNA Sciences YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Applied DNA Sciences's YoY EBITDA Growth for the fiscal year that ended in Sep. 2023 is calculated as:

	YoY EBITDA Growth (A: Sep. 2023 )
=	(EBITDA per Share (A: Sep. 2023 )	-	EBITDA per Share (A: Sep. 2022 ))	/	\| EBITDA per Share (A: Sep. 2022 ) \|
=	(-13.742	-	-28.585)	/	\| -28.585 \|
=	51.93 %

Applied DNA Sciences's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(-3.625	-	-3.417)	/	\| -3.417 \|
=	-6.09 %

Applied DNA Sciences YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Applied DNA Sciences's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Applied DNA Sciences (STU:UDJ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Applied DNA Sciences Inc (STU:UDJ) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

APDN:USA UDJP:Germany

Address

50 Health Sciences Drive, Stony Brook, New York, NY, USA, 11790

Website

https://www.adnas.com

Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) nd ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.

Applied DNA Sciences (STU:UDJ) Headlines

No Headlines